Home | Blog | Weight Loss | Can taking Wegovy help you age better?
As you age, you're naturally more vulnerable to diseases and illnesses. While this is partly due to genetics, environmental factors also play a role. Having an overweight BMI, living a sedentary lifestyle and eating an unhealthy diet increase your chances of developing chronic illnesses...

Summary:
- Wegovy can contribute to better health outcomes by addressing obesity, a key factor in age-related health issues.
- Treating obesity can reduce pressure on your joints and improve mobility, particularly if you have arthritis in your knees.
- Wegovy can help stabilise energy levels by improving insulin sensitivity and glucose absorption.
- Losing weight if you have obesity can lower your risk of diabetes, cardiovascular disease, and other conditions.
It’s never too late to make healthier lifestyle choices. Taking Wegovy can help prevent the risk of various health conditions you are exposed to, if you are overweight. It’s a weight loss drug that has the potential to help you live longer. It isn’t a miracle drug that can reverse ageing, but it can lessen physical restrictions later in life by improving your mobility and cardiovascular health, among other health factors.
Wegovy contains the active ingredient semaglutide, a GLP-1 receptor agonist. It works by controlling insulin secretion, delaying gastric emptying (how long it takes for food to leave your stomach), and suppressing your appetite.
Wegovy is a weight loss drug that helps regulate your blood sugar and weight. This can reduce your risk of developing certain illnesses as well as impact your overall health and ageing.
Here are some specific ways it can help you age better.
Mobility is the ability to move around comfortably and freely. As you get older your mobility decreases; approximately one third of adults aged over 65 find it difficult to walk.
Knee osteoarthritis (OA) can cause limited mobility, and it’s the most common source of knee pain in people over 50. One of the primary factors contributing to knee OA is obesity. Being overweight adds extra pressure on your knee joints, which can wear down your cartilage. This causes pain, making it hard to move around comfortably.
If you are overweight, your doctor will recommend losing weight and exercising. Wegovy can help you lose weight, which helps remove the pressure on the knees. This was assessed using the WOMAC scale (a questionnaire that measures the pain and stiffness in people with knee OA), where patients using semaglutide had a 41.7 point reduction in pain compared to 27.5 for the placebo group. Another study on the impact of semaglutide on OA found that it can help prevent the condition’s onset.
However it’s still important to do strength training exercises and eat a lot of protein to help maintain your muscle mass when losing weight. This is because you’re at a higher risk of developing sarcopenia when you’re older (a condition characterised by muscle loss).
When you’re older, you might find you need to nap more and sleep longer, which is normal. But sometimes, medical conditions like diabetes can be the reason for fatigue.
When you’re diabetic, high blood sugar levels can lower your energy levels, making you feel more tired than usual. Glucose is the main source of energy for your body, but with diabetes, your body can’t efficiently absorb it. This poor absorption leads to low energy levels. Other symptoms of diabetes, like dehydration, can further contribute to fatigue.
Wegovy, originally made as a diabetes medication, increases insulin sensitivity. This helps your body use insulin better, so it can move glucose into your cells and lower your blood sugar. It also helps control your appetite and manages the way food is broken down, making energy production more efficient. These combined effects — insulin regulation, improved food breakdown and appetite control — help stabilise your energy levels throughout the day.
However, these positive changes to your energy levels might not be immediate. Initially, you might feel more tired, which is a common side effect of semaglutide. But once your body adjusts to the medicine, the positive effects should follow.
Often, your sleep quality naturally worsens as you age. Whether that means waking up frequently during the night or sleeping more lightly. While these changes are normal and don’t typically require medication, using Wegovy may help if your sleep is being worsened by a condition like sleep apnoea.
Sleep apnoea is an obstructive condition where your breathing stops and starts repeatedly throughout the night, making it harder to breathe. It’s commonly linked to obesity, older age and type 2 diabetes.
With obesity, excess fat often accumulates around your respiratory tracts. This narrows them, making it harder to breathe. Losing weight can significantly improve sleep apnoea and is often recommended if you have overweight.
For patients with obesity-related sleep apnoea who struggle to lose weight, semaglutide might help. Some studies suggest semaglutide can reduce the severity of sleep apnoea, but more rigorous testing is needed for it to be considered a treatment for obesity-related sleep apnoea.
If you think Wegovy can help with your sleep apnoea, get in touch with our clinicians and they’ll decide whether it’s the right treatment for you.
As you get older, you often become more vulnerable to illnesses. This risk increases even more with obesity, so losing weight can significantly improve your health outcome. And losing it with Wegovy is even better.
Wegovy has been proven to:
We can’t say for sure that Wegovy is right for you. Health isn’t a one-size-fits-all approach, so what works for others might now work for you.
But if you’re living with obesity and have struggled to lose weight in the past, trying Wegovy might be worth it. Get in touch with our clinicians and they’ll discuss if Wegovy is right for you.
Semaglutide is a glucagon-like peptide-1 receptor agonist with cardiovascular benefits for the management of type 2 diabetes. Reviews in Endocrine & Metabolic Disorders, 23(3), 521-539.
Preserving Mobility in Older Adults with Physical Frailty and Sarcopenia: Opportunities, Challenges, and Recommendations for Physical Activity Interventions. [online] Clinical Interventions in Aging.
Increasing Prevalence of Knee Pain and Symptomatic Knee Osteoarthritis. Annals of Internal Medicine, 155(11), 725.
Chicago Arthritis. [online] Chicago Arthritis and Regenerative Medicine.
Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study. Obesity Science & Practice, 10(3), e762.
Semaglutide. [online] Nih.gov.
Obstructive Sleep Apnoea and Obesity: Implications for Public Health. Sleep Medicine and Disorders : International Journal, 1(4).
The potential impact of GLP-1 agonists on obstructive sleep apnoea. Respirology, 28(9), 824-825.
The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping Review. Pharmacy, 12(1).
Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis. Diabetol Metab Syndr 15, 218 (2023).
The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 12(3).
Effects of semaglutide on cardiovascular risk factors and eating behaviours in type 2 diabetes. Acta Diabetologica, 59(10), 1287-1294.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England Journal of Medicine, 389(24).
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. The Lancet Diabetes & Endocrinology, [online] 10(3), pp.193–206.
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.
Have a subject you’d like us to cover in a future article? Let us know.
We're making healthcare more about you. Sign up to our newsletter for personalised health articles that make a difference.
Disclaimer: The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment. If you have any questions or concerns about your health, please talk to a doctor.
We couldn't find what you're looking for.
Here's everything we treat. Or, if you're looking for something we don't have yet, you can suggest something.
By clicking 'Subscribe now' you're agreeing to our Privacy Policy.
(And leave your email too, so we can let you know if we write an article based on your suggestion.)
Last updated on Oct 18, 2024.
Our experts continually monitor new findings in health and medicine, and we update our articles when new info becomes available.
Oct 18, 2024
Published by: The Treated Content Team. Medically reviewed by: Mr Craig Marsh, Independent PrescriberHow we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.